AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius Medical Care AG & Co. KGaA

Earnings Release May 4, 2011

165_rns_2011-05-04_a2347128-cf09-47c8-b8ac-d04a891f638c.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 4 May 2011 06:52

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care Reports First Quarter 2011 Results and Raises Outlook for 2011

Fresenius Medical Care AG & Co. KGaA / Key word(s): Quarter Results/Change in Forecast

04.05.2011 06:52

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Fresenius Medical Care Reports First Quarter 2011 Results and Raises
Outlook for 2011

Net revenue of Fresenius Medical Care AG & Co. KGaA increased by 5% to
$3,036 million (+5% at constant currency) in the first quarter of 2011.
Operating income (EBIT) increased by 5% to $445 million. Net income for the
first quarter of 2011 was $221 million, an increase of 5%.

Based on the strong financial results in the first quarter of 2011 and the
elimination of the so-called 'transition adjustment' imposed on dialysis
facilities as part of the new Medicare end-stage renal disease prospective
payment system in the United States, the company raises its outlook for the
full year 2011.

The company now expects to achieve revenue of more than $13 billion.
Previously, the company expected revenue to grow to between $12.8 billion
and $13.0 billion.

Net income attributable to Fresenius Medical Care AG & Co. KGaA is now
expected to be between $1.070 billion to $1.090 billion in 2011.
Previously, the company expected net income to be between $1.035 billion
and $1.055 billion.

For 2011, the company still expects to spend around 5% of revenue on
capital expenditures and approximately $1.2 billion on acquisitions. The
debt/EBITDA ratio is expected to be below or equal to 2.8 by the end of
2011, likewise unchanged from the previous guidance.

Fresenius Medical Care AG & Co. KGaA,
represented by Fresenius Medical Care Management AG,
Board of Management,
Bad Homburg v.d.H., May 4, 2011

04.05.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Deutschland
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: [email protected]
Internet: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX; NYSE

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.